This Article Full Text Full Text (PDF) All Versions of this Article: 25/10/2032    most recent 01.ATV.0000183728.14712.d8v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lafontan, M. Articles by Berlan, M. Search for Related Content PubMed PubMed Citation Articles by Lafontan, M. Articles by Berlan, M.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2032.)
© 2005 American Heart Association, Inc.

Brief Reviews

An Unsuspected Metabolic Role for Atrial Natriuretic Peptides

The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans

Max Lafontan; Cédric Moro; Coralie Sengenes; Jean Galitzky; François Crampes; Michel Berlan

From the IFR31-Institut Louis Bugnard; Hôpital Rangueil, Institut National de la Santé et de la Recherche Médicale (Inserm), Inserm U586; the Obesity Research Unit; BP 84 225; 31432 Toulouse cedex 4; and the Université Paul Sabatier, 31052 Toulouse cedex 4, France.

Correspondence to Doctor Max Lafontan, IFR-31, Institut Louis Bugnard, Obesity Research Unit, Inserm-UPS U 586, BP 84225, 31432 Toulouse cedex 4, France. E-mail Max.Lafontan{at}toulouse.inserm.fr

In normal and obese humans, lipid mobilization and systemic nonesterified fatty acid levels are thought to be acutely controlled by catecholamines (ie, epinephrine and norepinephrine) and insulin. Natriuretic peptides (NPs) are known to play a key role in the regulation of salt and water balance and blood pressure homeostasis. They are involved in the pathophysiology of hypertension and heart failure. NPs have recently been found to exert potent lipolytic effects (ie, activating the breakdown of stored triacylglycerols) in isolated human fat cells and to promote lipid mobilization in vivo. Atrial natriuretic peptide increases the intracellular 3', 5'-cyclic guanosine monophosphate (cGMP) concentration which activates cGMP-dependent protein kinase leading to perilipin and hormone-sensitive lipase phosphorylation and lipolysis. NPs promote lipid mobilization when administered intravenously. NPs are also responsible for the residual lipid-mobilizing action observed under oral ß-blockade in subjects performing physical exercise. NPs are therefore novel factors which may open promising research pathways to explain the control of lipid mobilization in physiological and pathological conditions. The metabolic impact of altered production and circulation of NPs remains to be established. The potential influence of NPs on the development of lipid disorders, obesity-related cardiovascular events, and cardiac cachexia will be discussed in this review.

Natriuretic peptides (NPs) are novel factors which may open promising research pathways to explain the control of lipid mobilization in physiological and pathological conditions. The metabolic impact of altered production and circulation of NPs remains to be established. The potential influence of NPs on the development of lipid disorders, obesity-related cardiovascular events, and cardiac cachexia will be discussed in this review.

Key Words: adipose tissue • adipocytes • lipolysis • natriuretic peptides • obesity • lipid metabolism • lipid mobilization • insulin

This article has been cited by other articles:

				K. R. Kaun, M. Chakaborty-Chatterjee, and M. B. Sokolowski Natural variation in plasticity of glucose homeostasis and food intake J. Exp. Biol., October 1, 2008; 211(19): 3160 - 3166. [Abstract] [Full Text] [PDF]

				C. Christoffersen, I. Hunter, A. L. Jensen, and J. P. Goetze Diabetes and the endocrine heart Eur. Heart J., October 2, 2007; 28(20): 2427 - 2429. [Full Text] [PDF]

				T. J. Wang, M. G. Larson, M. J. Keyes, D. Levy, E. J. Benjamin, and R. S. Vasan Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals Circulation, March 20, 2007; 115(11): 1345 - 1353. [Abstract] [Full Text] [PDF]